• 011-26907444
  • raghava@iiitd.ac.in

Welcome to Peptide Card of AntiTbPdb

This page displays user query in tabular form.

ILSLRWRWKWWKK details
Primary information
ID antitb_1912,
Name26902758
N-Terminal modificationNone
C-Terminal ModificationILSLRWRWKWWKK
Chemical ModificationFree
Linear/CyclicFree
LengthNone
ChiralityLinear
Nature13
SourceL
OriginCationic
SpeciesSynthetic
Inhibition ConcentrationMycobacterium smegmatis
In Vitro/ In vivoMycobacterium smegmatis
Cell LineMIC = 8 μM
Inhibition ConcentrationIn vitro
Sequence2016
CytotoxicityJ774.16 mouse macrophages and A549 human lung epithelial cells
In vivo ModelNA
Lethal DoseNo cytotoxicity against J774.16 mouse macrophages and A549 human lung epithelial cells
Immune ResponceNA
Mechanism of ActionNA
TargetNA
Combination TherapyNA
Other activitiesLipid bilayer
PMIDNA
Year of PublicationAntibacterial against Streptococcus pyogenes, Streptococcus agalactiae, Streptococcus pneumoniae ATCC 49619, Klebsiella pneumoniae, Pseudomonas aeruginosa ATCC27853, Bacillus subtilis BGSC 1A1.
Tertiary Structure
(Technique)
Not Predicted),
Primary information
ID antitb_1913,
Name26902758
N-Terminal modificationNone
C-Terminal ModificationILSLRWRWKWWKK
Chemical ModificationFree
Linear/CyclicFree
LengthNone
ChiralityLinear
Nature13
SourceL
OriginCationic
SpeciesSynthetic
Inhibition ConcentrationMycobacterium tuberculosis
In Vitro/ In vivoMycobacterium tuberculosis mc2 6020
Cell LineMIC = 32 μM
Inhibition ConcentrationIn vitro
Sequence2016
CytotoxicityJ774.16 mouse macrophages and A549 human lung epithelial cells
In vivo ModelNA
Lethal DoseNo cytotoxicity against J774.16 mouse macrophages and A549 human lung epithelial cells
Immune ResponceNA
Mechanism of ActionNA
TargetNA
Combination TherapyNA
Other activitiesLipid bilayer
PMIDNA
Year of PublicationAntibacterial against Streptococcus pyogenes, Streptococcus agalactiae, Streptococcus pneumoniae ATCC 49619, Klebsiella pneumoniae, Pseudomonas aeruginosa ATCC 27853, Bacillus subtilis BGSC 1A1.
Tertiary Structure
(Technique)
Not Predicted),
Primary information
ID antitb_1914,
Name26902758
N-Terminal modificationNone
C-Terminal ModificationILSLRWRWKWWKK
Chemical ModificationFree
Linear/CyclicFree
LengthNone
ChiralityLinear
Nature13
SourceL
OriginCationic
SpeciesSynthetic
Inhibition ConcentrationMycobacterium bovis
In Vitro/ In vivoMycobacterium bovis BCG pasteur strain
Cell LineMIC = 32 μM
Inhibition ConcentrationIn vitro
Sequence2016
CytotoxicityJ774.16 mouse macrophages and A549 human lung epithelial cells
In vivo ModelNA
Lethal DoseNo cytotoxicity against J774.16 mouse macrophages and A549 human lung epithelial cells
Immune ResponceNA
Mechanism of ActionNA
TargetNA
Combination TherapyNA
Other activitiesLipid bilayer
PMIDNA
Year of PublicationAntibacterial against Streptococcus pyogenes, Streptococcus agalactiae, Streptococcus pneumoniae ATCC 49619, Klebsiella pneumoniae, Pseudomonas aeruginosa ATCC 27853, Bacillus subtilis BGSC 1A1.
Tertiary Structure
(Technique)
Not Predicted),